Published in Appl Microbiol on September 01, 1974
Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94
Pyrazinamidase activity in Yersinia enterocolitica and related organisms. J Clin Microbiol (1985) 2.83
Isolation of Yersinia enterocolitica from raw milk. Appl Environ Microbiol (1978) 2.29
Recovery of Yersinia enterocolitica from streams and lakes of California. Appl Environ Microbiol (1976) 2.08
Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04
Isolation of Yersinia enterocolitica from swine. J Clin Microbiol (1975) 2.01
Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99
Yersinia enterocolitica isolates from humans in California, 1968-1975. J Clin Microbiol (1976) 1.91
Yersinia enterocolitica in adults with gastrointestinal disturbances: need for cold enrichment. J Clin Microbiol (1980) 1.82
Characteristics of Yersinia enterocolitica and related species isolated from human, animal, and environmental sources. J Clin Microbiol (1981) 1.67
Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59
Nonvalue of cold enrichment of stools for isolation of Yersinia enterocolitica serotypes 3 and 9 from patients. J Clin Microbiol (1980) 1.54
Isolation of Yersinia enterocolitica from well water and growth in distilled water. Appl Environ Microbiol (1977) 1.38
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3. Antimicrob Agents Chemother (1977) 1.34
Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother (1978) 1.30
Family outbreak of yersiniosis. J Clin Microbiol (1982) 1.30
Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol (1982) 1.28
Medium for isolation of Yersinia enterocolitica. J Clin Microbiol (1979) 1.17
Yersinia enterocolitica : a review of its role in food hygiene. Bull World Health Organ (1976) 1.13
In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics. Antimicrob Agents Chemother (1985) 1.12
Improved procedure for recovery of Yersinia enterocolitica from meats. Appl Environ Microbiol (1983) 1.08
Enteropathogenic bacteria in frozen chicken. Appl Environ Microbiol (1981) 1.07
Distribution of pathogenic Yersinia enterocolitica in China. Eur J Clin Microbiol Infect Dis (2009) 1.05
Yersinia enterocolitica septicemia with pneumonia. Can Med Assoc J (1979) 1.01
Letter: Incidence of Yersinia enterocolitica and Y. pseudotuberculosis infections in Canada; 1975 semiannual report. Can Med Assoc J (1976) 0.95
Yersinia enterocolitica: Mode of Transmission, Molecular Insights of Virulence, and Pathogenesis of Infection. J Pathog (2011) 0.94
Experience with Yersinia enterocolitica at The Hospital for Sick Children, 1972-74. Can Med Assoc J (1975) 0.92
Faecal carriage rate of Yersinia species. J Hyg (Lond) (1986) 0.91
Yersinia enterocolitica and related species isolated from wildlife in New York State. Appl Environ Microbiol (1986) 0.90
In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products. Antimicrob Agents Chemother (1990) 0.88
Homology analysis of pathogenic Yersinia species Yersinia enterocolitica, Yersinia pseudotuberculosis, and Yersinia pestis based on multilocus sequence typing. J Clin Microbiol (2013) 0.88
Differential and selective medium for isolation of Yersinia enterocolitica from stools. J Clin Microbiol (1982) 0.86
Septicemia caused by Yersinia enterocolitica. Can Med Assoc J (1978) 0.86
Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990. Antimicrob Agents Chemother (1994) 0.78
An inter-familial outbreak of Yersinia enterocolitica enteritis. N Engl J Med (1973) 3.14
Two community outbreaks of human infection with Yersinia enterocolitica. J Hyg (Lond) (1973) 2.97
Yersinia enterocolitica in drinking-water. Scand J Infect Dis (1972) 2.79
Survey on the incidence of Yersinia enterocolitica in the province of Ontario. Can J Public Health (1974) 2.77
Hospital outbreak of Yersinia enterocolitica infection. Lancet (1973) 2.56
[Supplement to the antigenic schema of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1972) 2.52
Yersinia enterocolitica. N Engl J Med (1970) 2.34
Human yersiniosis in Finland. II. Clinical features. Ann Clin Res (1972) 2.07
[Yersinia enterocolitica: biologic, epidemiologic and clinical aspects of 67 cases observed at Hôpital Sainte-Justine (Montreal, Canada)]. Union Med Can (1972) 2.06
An outbreak of enteritis due to Yersinia enterocolitica occurring at a junior high school. Jpn J Microbiol (1973) 2.02
Septicemia due to Yersinia enterocolitica. Can Med Assoc J (1973) 1.83
Yersiniosis in children. Can Med Assoc J (1974) 1.50
Yersinia enterocolitica infection: report of two cases. Can J Public Health (1973) 1.49
Yersinia enterocolitica isolated from animals in the Fraser Valley of British Columbia. Can Vet J (1972) 1.32
[A new field in pathology: Yersinia enterocolitica infections]. Ann Biol Clin (Paris) (1972) 1.27
Enteritis due to Yersinia enterocolitica. J Pediatr (1974) 1.08
Survey on the incidence of Yersinia enterocolitica in the province of Ontario. Can J Public Health (1974) 2.77
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73
A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med (1984) 2.35
Isolation of Yersinia enterocolitica from raw milk. Appl Environ Microbiol (1978) 2.29
Characteristics of virulence in human isolates of Yersinia enterocolitica. Infect Immun (1981) 2.22
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
[Yersinia enterocolitica: biologic, epidemiologic and clinical aspects of 67 cases observed at Hôpital Sainte-Justine (Montreal, Canada)]. Union Med Can (1972) 2.06
Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04
Isolation of Yersinia enterocolitica from swine. J Clin Microbiol (1975) 2.01
Neisseria gonorrhoeae: evaluation of some methods used for carbohydrate utilization. Can J Microbiol (1978) 1.85
Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium. J Clin Microbiol (1989) 1.74
IgM in bone marrow-derived lymphocytes. Synthesis, surface deposition, turnover and carbohydrate composition in unstimulated mouse B cells. Eur J Immunol (1974) 1.71
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Broad-spectrum enzyme-linked immunosorbent assay for detection of Legionella soluble antigens. J Clin Microbiol (1986) 1.68
Canadian experience with Yersinia enterocolitica (1966--1977). Contrib Microbiol Immunol (1979) 1.68
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr (1992) 1.56
Resistance to trimethoprim and other antibiotics in Ontario shigellae. Lancet (1980) 1.55
Yersiniosis in children. Can Med Assoc J (1974) 1.50
Yersinia enterocolitica infection: report of two cases. Can J Public Health (1973) 1.49
Human and nonhuman infections caused by Yersinia pseudotuberculosis in Canada from 1962 to 1985. J Clin Microbiol (1986) 1.43
Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron (1996) 1.38
Raman studies of nucleic acids. VII. Poly A-poly U and poly G-poly C. Biopolymers (1972) 1.30
Opposite effects of BCG on spleen and lymph node cells: lymphocyte proliferation and immunoglobulin synthesis. Infect Immun (1978) 1.29
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
Cloning of a novel pilin-like gene from Bordetella pertussis: homology to the fim2 gene. Mol Microbiol (1988) 1.21
Detection of Legionella antigenuria by reverse passive agglutination. J Clin Microbiol (1982) 1.20
Legionella bozemanii serogroup 2: a new etiological agent. J Clin Microbiol (1984) 1.19
O:13a,13b, a new pathogenic serotype of Yersinia enterocolitica. J Clin Microbiol (1984) 1.19
Isolation of Mycoplasma pneumoniae from respiratory tract specimens in Ontario. CMAJ (1987) 1.18
Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology (2008) 1.16
Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem Biophys Res Commun (1996) 1.14
Suppressor cells in rabbit peripheral blood. Eur J Immunol (1976) 1.06
Restriction of specificity in the precursors of bone marrow-associated lymphocytes. J Exp Med (1973) 1.05
Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int (1997) 1.02
Contact interactions method: a new algorithm for protein folding simulations. Protein Sci (1996) 1.01
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas. Invest New Drugs (2006) 1.00
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Ann Oncol (1997) 0.99
Legionella oakridgensis: laboratory diagnosis of a human infection. J Clin Microbiol (1985) 0.98
Evidence for readily induced tolerance to heterologous erythrocytes in nude mice. Scand J Immunol (1974) 0.97
Detection of urinary antigens of Legionella pneumophila serogroup 12 by broad-spectrum enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 0.95
Letter: Incidence of Yersinia enterocolitica and Y. pseudotuberculosis infections in Canada; 1975 semiannual report. Can Med Assoc J (1976) 0.95
Single unit responses of human cutaneous mechanoreceptors to air-puff stimulation. Clin Neurophysiol (2000) 0.95
Nocturnal variation in human sympathetic baroreflex sensitivity. J Auton Nerv Syst (1998) 0.93
Infection caused by Yersinia enterocolitica serotype O:21. J Clin Microbiol (1982) 0.92
Legionnaires' disease caused by Legionella pneumophila serogroup 3. Lancet (1979) 0.92
Isolation of Legionella pneumophila, serogroup 6 in Canada. Can Med Assoc J (1981) 0.91
Inhibition and synchronisation of tremor induced by a muscle twitch. J Neurol Neurosurg Psychiatry (1980) 0.91
Clinical pharmacokinetics of tretinoin. Clin Pharmacokinet (1997) 0.90
Cloning of rat and human kynurenine aminotransferase. Adv Exp Med Biol (1996) 0.89
Differentiation of lymphocytes: characterization of early precursors of B lymphocytes. Ser Haematol (1972) 0.89
Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet (1994) 0.88
Arterial catheter-related infections in children. A 1-year cohort analysis. Am J Dis Child (1991) 0.88
Bordetella pertussis serotypes in Canada. Can Med Assoc J (1978) 0.88
nprR1 and nprR2 regulatory regions for neutral protease expression in Bacillus subtilis. J Bacteriol (1986) 0.88
Staining of micronuclei in squamous epithelial cells of human oral mucosa. Anal Quant Cytol Histol (1997) 0.88
Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer. Cancer (1990) 0.88
Antibiotic susceptibility of blood and cerebrospinal fluid isolates of Haemophilus influenzae. J Antimicrob Chemother (1985) 0.88
Heterogeneity of endothelial cells of adult rat liver as resolved by sedimentation velocity and flow cytometry. J Cell Physiol (1984) 0.87
Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study. Eur J Cancer (1999) 0.87
Structural features of neutral protease from Bacillus subtilis deduced from model-building and limited proteolysis experiments. Eur J Biochem (1990) 0.86
Intracerebral source localization of mental process-related potentials elicited prior to mental sweating response in humans. Neurosci Lett (1998) 0.85
Characteristics of the interaction of a treponemal hemolysin with rabbit erythrocytes. Biochimie (1980) 0.84
New plasmid expression vectors for Bacillus subtilis. Plasmid (1986) 0.83
Nalidixic acid analogues and Shigella. Lancet (1984) 0.83
Changes in mixed lymphocyte culture-reactive lymphocytes following alloimmunization of single lymph nodes in sheep. Transplantation (1979) 0.82
Ultrasound effects on the photopinacolization of benzophenone. J Org Chem (2000) 0.82
Major changes in surface membrane proteins during erythropoiesis. Biochem Biophys Res Commun (1975) 0.82
Detection of Hepatitis E Virus (HEV) in Italian pigs displaying different pathological lesions. Res Vet Sci (2010) 0.82
Inhibitory effect of acupuncture on the vibration-induced finger flexion reflex in man. Electroencephalogr Clin Neurophysiol (1985) 0.82
Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am J Respir Crit Care Med (1997) 0.82
Sonographic evaluation of local recurrences of soft tissue sarcomas. J Ultrasound Med (1993) 0.82
Secretory carcinoma of the breast. Report of a case with fine needle aspiration biopsy. Acta Cytol (1986) 0.82
Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study. Neuroscience (2013) 0.81
Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines. Anticancer Res (2000) 0.81
Comparison of conventional and ultrasonically assisted extractions of pharmaceutically active compounds from Salvia officinalis. Ultrason Sonochem (1997) 0.81
Ultrasound effects on photochemical reactions, part 1: photochemical reactions of ketones with alkenes. Ultrason Sonochem (1997) 0.81
Incidence of infection related to arterial catheterization in children: a prospective study. Crit Care Med (1988) 0.80
Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding. Biochemistry (2000) 0.80
The effects of therapy on estrogen receptors in breast cancer. J Steroid Biochem (1985) 0.79
Monoclonal antibodies against histone H5. Epitope mapping and binding to chromatin. J Biol Chem (1985) 0.79
[Salmonellosis in children: study of 95 cases in the Hospital Ste-Justine, Montreal, in 1963-1964]. Can Med Assoc J (1966) 0.79
Primary tumor site, size, patients age and axillary lymph nodes in breast cancers. Tumori (1986) 0.79
Release of low density lipoprotein receptors from human fibroblasts or HeLa cells by tryptic digestion. Biochem Biophys Res Commun (1978) 0.79
Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer. Am J Hematol (2002) 0.78
Disseminated Legionella pneumophila infection in an infant with severe combined immunodeficiency. J Pediatr (1982) 0.78
Grafting in revision rhinoplasty. Acta Otorhinolaryngol Ital (2013) 0.78
Resistance to trimethoprim and other antibiotics in shigellae isolated in the province of Ontario. Can J Microbiol (1980) 0.78
Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer (1997) 0.78
Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. Am J Clin Oncol (1988) 0.78
Folding simulation of protein models on the structure-based cubo-octahedral lattice with the Contact Interactions algorithm. Protein Sci (1999) 0.78
Different techniques for drug cytotoxicity evaluation on MCF-7 human breast cancer cell line. Anticancer Res (1987) 0.77
Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study. Eur J Cancer (1995) 0.77
Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. Int J Cancer (1996) 0.77
Probing the structure of human growth hormone by limited proteolysis. Int J Pept Protein Res (1995) 0.77
Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma. Cancer Lett (1992) 0.77
Attenuation of somatosensory evoked potentials by acupuncture and tactile skin stimulation in man. Brain Topogr (1991) 0.77
Morquio-like syndrome (MPS IV B) associated with deficiency of a beta-galactosidase. Johns Hopkins Med J (1980) 0.77
Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study. Oncol Rep (1998) 0.76